PURPOSE: The Ontario site of the Cooperative Family Registry for Breast Cancer Studies collects cancer family history, other risk factor information, and biospecimens from individuals with incident breast cancer and their relatives within a defined population. Sampling is based on age and defined genetic risk criteria. The purpose of this analysis was to evaluate the representativeness of the respondents. METHODS: We examined characteristics associated with response to requests for information, biospecimens, and permission to contact relatives among those diagnosed with breast cancer in 1996 in the province of Ontario. RESULTS: Overall, response was good among the largest group, white women, and did not differ between those with and without a family history of breast and/or ovarian cancer. Women who described themselves as other than white and men tended to have lower response. Women of Ashkenazi heritage had high response except for permission to contact relatives. CONCLUSIONS: There was no evidence that participation in a familial breast cancer registry derived from a population-based cancer registry was influenced by having a family history of breast or ovarian cancer. The use of a cancer registry approach is likely more representative of the population than clinic-based recruitment of families for genetic studies.
PURPOSE: The Ontario site of the Cooperative Family Registry for Breast Cancer Studies collects cancer family history, other risk factor information, and biospecimens from individuals with incident breast cancer and their relatives within a defined population. Sampling is based on age and defined genetic risk criteria. The purpose of this analysis was to evaluate the representativeness of the respondents. METHODS: We examined characteristics associated with response to requests for information, biospecimens, and permission to contact relatives among those diagnosed with breast cancer in 1996 in the province of Ontario. RESULTS: Overall, response was good among the largest group, white women, and did not differ between those with and without a family history of breast and/or ovarian cancer. Women who described themselves as other than white and men tended to have lower response. Women of Ashkenazi heritage had high response except for permission to contact relatives. CONCLUSIONS: There was no evidence that participation in a familial breast cancer registry derived from a population-based cancer registry was influenced by having a family history of breast or ovarian cancer. The use of a cancer registry approach is likely more representative of the population than clinic-based recruitment of families for genetic studies.
Authors: Marcelo Sobral-Leite; Koen Van de Vijver; Magali Michaut; Rianne van der Linden; Gerrit K J Hooijer; Hugo M Horlings; Tesa M Severson; Anna Marie Mulligan; Nayana Weerasooriya; Joyce Sanders; Annuska M Glas; Diederik Wehkamp; Lorenza Mittempergher; Kelly Kersten; Ashley Cimino-Mathews; Dennis Peters; Erik Hooijberg; Annegien Broeks; Marc J van de Vijver; Rene Bernards; Irene L Andrulis; Marleen Kok; Karin E de Visser; Marjanka K Schmidt Journal: Oncoimmunology Date: 2018-09-11 Impact factor: 8.110
Authors: Michael A Campitelli; Anna M Chiarelli; Lucia Mirea; Lindsay Stewart; Gord Glendon; Paul Ritvo; Irene L Andrulis; Julia A Knight Journal: Eur J Cancer Prev Date: 2011-11 Impact factor: 2.497
Authors: Roger L Milne; Esther M John; Julia A Knight; Gillian S Dite; Melissa C Southey; Graham G Giles; Carmel Apicella; Dee W West; Irene L Andrulis; Alice S Whittemore; John L Hopper Journal: Int J Epidemiol Date: 2011-07-19 Impact factor: 7.196
Authors: Catherine L Forse; Dushanthi Pinnaduwage; Shelley B Bull; Anna Marie Mulligan; Irene L Andrulis Journal: Appl Immunohistochem Mol Morphol Date: 2019-03
Authors: Meghan J Walker; Lucia Mirea; Kristine Cooper; Mitra Nabavi; Gord Glendon; Irene L Andrulis; Julia A Knight; Frances P O'Malley; Anna M Chiarelli Journal: Fam Cancer Date: 2014-06 Impact factor: 2.375
Authors: Sean P Cleary; Hyeja Kim; Marina E Croitoru; Mark Redston; Julia A Knight; Steven Gallinger; Robert Gryfe Journal: Dis Colon Rectum Date: 2008-07-10 Impact factor: 4.585
Authors: Ellen T Chang; Roger L Milne; Kelly-Anne Phillips; Jane C Figueiredo; Meera Sangaramoorthy; Theresa H M Keegan; Irene L Andrulis; John L Hopper; Pamela J Goodwin; Frances P O'Malley; Nayana Weerasooriya; Carmel Apicella; Melissa C Southey; Michael L Friedlander; Graham G Giles; Alice S Whittemore; Dee W West; Esther M John Journal: Breast Cancer Res Treat Date: 2008-11-26 Impact factor: 4.872
Authors: Meghan J Walker; Lucia Mirea; Gord Glendon; Paul Ritvo; Irene L Andrulis; Julia A Knight; Anna M Chiarelli Journal: Breast Date: 2014-05-10 Impact factor: 4.380